Skip to content

An expanded study on the clinical efficacy and medication characteristics of Heng-Gu-Gu-Shang-Yu-He-Ji in Fracture Treatment: A Real-World Study

An expanded study on the clinical efficacy and medication characteristics of Heng-Gu-Gu-Shang-Yu-He-Ji in Fracture Treatment: A Real-World Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2025001387
Enrollment
Unknown
Registered
2025-07-11
Start date
2025-05-01
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fracture

Interventions

Exposure group:None
Non-exposed group:None

Sponsors

Beijing University Of Chinese Medicine Third Affiliated Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Meet the Western medical diagnostic criteria for fractures. 2.Test group: minimum consumption of 150ml of OsteoKing; Control group: no consumption of Henggu Bone Injury Healing Agent. 3. At least one follow-up imaging review post-treatment. 4. Age between 15 and 85 years.

Exclusion criteria

Exclusion criteria: 1.Pathological fractures due to benign or malignant tumors tuberculosis osteomyelitis etc. 2.Patients with psychiatric disorders glaucoma breastfeeding women pregnant women or women planning pregnancy in the near future. 3.Patients in critical condition where evaluating the drug's safety and effectiveness is challenging. Cases of death during hospitalization.

Design outcomes

Primary

MeasureTime frame
Condition of swelling;Imageological examination;Visual Analogue Scale;

Secondary

MeasureTime frame
Bone mineral density examination room;General information: age, gender, occupation, admission condition, admission department, length of hospital stay, etc;Liver and kidney function indexes;Medication characteristics: dosage, course of treatment, combined medication;Clinical signs: presence or absence of tenderness, percussion pain, and abnormal activity;Adverse reactions, such as dry mouth, dizziness, nausea, vomiting, diarrhea, etc;Analysis of TCM syndromes/symptoms and signs;

Countries

China

Contacts

Public ContactWeiheng Chen

Beijing University Of Chinese Medicine Third Affiliated Hospital

drchenweiheng@163.com+86 135 1101 3261

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026